Financhill
Buy
55

TMUS Quote, Financials, Valuation and Earnings

Last price:
$220.30
Seasonality move :
8.46%
Day range:
$217.99 - $221.47
52-week range:
$153.84 - $248.15
Dividend yield:
1.29%
P/E ratio:
25.12x
P/S ratio:
3.26x
P/B ratio:
3.98x
Volume:
8.9M
Avg. volume:
3.9M
1-year change:
42.56%
Market cap:
$255.7B
Revenue:
$78.6B
EPS (TTM):
$8.77
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $45B $68.4B $80.1B $79.6B $78.6B
Revenue Growth (YoY) 3.9% 52% 17.14% -0.68% -1.27%
 
Cost of Revenues $18.5B $28.3B $36.6B $36.2B $30.2B
Gross Profit $26.5B $40.1B $43.5B $43.4B $48.4B
Gross Profit Margin 58.84% 58.67% 54.31% 54.5% 61.57%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $14.1B $18.9B $20.2B $21.6B $21.3B
Other Inc / (Exp) -$8M -$823M -$199M -$1.6B $93M
Operating Expenses $20.8B $33.1B $36.6B $35.3B $34.1B
Operating Income $5.7B $7.1B $6.9B $8.1B $14.2B
 
Net Interest Expenses $1.1B $2.7B $3.3B $3.4B $3.3B
EBT. Incl. Unusual Items $4.6B $3.5B $3.4B $3.1B $11B
Earnings of Discontinued Ops. -- $320M -- -- --
Income Tax Expense $1.1B $786M $327M $556M $2.7B
Net Income to Company $3.5B $3.1B $3B $2.6B $8.3B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $3.5B $3.1B $3B $2.6B $8.3B
 
Basic EPS (Cont. Ops) $4.06 $2.68 $2.42 $2.07 $7.02
Diluted EPS (Cont. Ops) $4.02 $2.65 $2.41 $2.06 $6.93
Weighted Average Basic Share $854.1M $1.1B $1.2B $1.2B $1.2B
Weighted Average Diluted Share $863.4M $1.2B $1.3B $1.3B $1.2B
 
EBITDA $12.4B $20.4B $23.1B $20.2B $27.2B
EBIT $5.7B $6.2B $6.7B $6.5B $14.3B
 
Revenue (Reported) $45B $68.4B $80.1B $79.6B $78.6B
Operating Income (Reported) $5.7B $7.1B $6.9B $8.1B $14.2B
Operating Income (Adjusted) $5.7B $6.2B $6.7B $6.5B $14.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $19.3B $19.6B $19.5B $19.3B $20.2B
Revenue Growth (YoY) 74.23% 1.83% -0.75% -1.16% 4.73%
 
Cost of Revenues $7.7B $8.7B $8.7B $7.1B $7B
Gross Profit $11.6B $10.9B $10.8B $12.1B $13.1B
Gross Profit Margin 60.14% 55.75% 55.36% 62.94% 65.14%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $4.9B $5.2B $5.1B $5.3B $5.2B
Other Inc / (Exp) -$99M -$60M -$1.1B $41M $7M
Operating Expenses $9B $9.4B $8.4B $8.5B $8.3B
Operating Income $2.6B $1.6B $2.4B $3.6B $4.8B
 
Net Interest Expenses $806M $836M $827M $790M $836M
EBT. Incl. Unusual Items $1.7B $688M $451M $2.8B $4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $407M -$3M -$57M $705M $908M
Net Income to Company $1.3B $691M $508M $2.1B $3.1B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.3B $691M $508M $2.1B $3.1B
 
Basic EPS (Cont. Ops) $1.01 $0.55 $0.40 $1.83 $2.62
Diluted EPS (Cont. Ops) $1.00 $0.55 $0.40 $1.82 $2.61
Weighted Average Basic Share $1.2B $1.2B $1.3B $1.2B $1.2B
Weighted Average Diluted Share $1.2B $1.3B $1.3B $1.2B $1.2B
 
EBITDA $6.6B $5.7B $4.6B $6.8B $8B
EBIT $2.5B $1.5B $1.3B $3.6B $4.8B
 
Revenue (Reported) $19.3B $19.6B $19.5B $19.3B $20.2B
Operating Income (Reported) $2.6B $1.6B $2.4B $3.6B $4.8B
Operating Income (Adjusted) $2.5B $1.5B $1.3B $3.6B $4.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $59.9B $79.7B $80.1B $78.4B $80B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $23.8B $35.8B $38B $30.5B $29.3B
Gross Profit $36.1B $43.9B $42.1B $47.9B $50.7B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $17.8B $19.6B $21.4B $21.6B $20.7B
Other Inc / (Exp) -$718M -$287M -$1.6B $67M $31M
Operating Expenses $29.5B $36.3B $35.7B $34.4B $33.8B
Operating Income $6.6B $7.5B $6.4B $13.5B $16.9B
 
Net Interest Expenses $2.2B $3.3B $3.4B $3.3B $3.4B
EBT. Incl. Unusual Items $3.7B $3.9B $1.4B $10.3B $13.5B
Earnings of Discontinued Ops. $320M -- -- -- --
Income Tax Expense $929M $591M -$87M $2.5B $3.1B
Net Income to Company $3.1B $3.4B $1.5B $7.8B $10.4B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $3.1B $3.4B $1.5B $7.8B $10.4B
 
Basic EPS (Cont. Ops) $3.09 $2.68 $1.22 $6.47 $8.86
Diluted EPS (Cont. Ops) $3.06 $2.67 $1.22 $6.44 $8.77
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $17.6B $24B $19.1B $26.4B $30B
EBIT $5.9B $7.2B $4.8B $13.6B $16.9B
 
Revenue (Reported) $59.9B $79.7B $80.1B $78.4B $80B
Operating Income (Reported) $6.6B $7.5B $6.4B $13.5B $16.9B
Operating Income (Adjusted) $5.9B $7.2B $4.8B $13.6B $16.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $48.1B $59.3B $59.3B $58.1B $59.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $18.6B $26.2B $27.5B $21.8B $20.9B
Gross Profit $29.4B $33.2B $31.8B $36.3B $38.7B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $14.2B $14.8B $16B $16B $15.5B
Other Inc / (Exp) -$722M -$186M -$1.6B $81M $19M
Operating Expenses $24.1B $27.4B $26.4B $25.5B $25.2B
Operating Income $5.3B $5.8B $5.3B $10.8B $13.4B
 
Net Interest Expenses $1.9B $2.5B $2.5B $2.5B $2.6B
EBT. Incl. Unusual Items $2.7B $3.1B $1.2B $8.4B $10.9B
Earnings of Discontinued Ops. $320M -- -- -- --
Income Tax Expense $715M $520M $106M $2.1B $2.5B
Net Income to Company $2.3B $2.6B $1.1B $6.3B $8.4B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $2.3B $2.6B $1.1B $6.3B $8.4B
 
Basic EPS (Cont. Ops) $2.21 $2.08 $0.88 $5.28 $7.12
Diluted EPS (Cont. Ops) $2.19 $2.07 $0.88 $5.26 $7.10
Weighted Average Basic Share $3.3B $3.7B $3.8B $3.6B $3.5B
Weighted Average Diluted Share $3.4B $3.8B $3.8B $3.6B $3.5B
 
EBITDA $14.6B $18.2B $14.2B $20.3B $23.2B
EBIT $4.6B $5.6B $3.8B $10.8B $13.4B
 
Revenue (Reported) $48.1B $59.3B $59.3B $58.1B $59.5B
Operating Income (Reported) $5.3B $5.8B $5.3B $10.8B $13.4B
Operating Income (Adjusted) $4.6B $5.6B $3.8B $10.8B $13.4B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $1.5B $10.4B $6.6B $4.5B $5.1B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.9B $4.3B $4.2B $4.4B $4.7B
Inventory $964M $2.5B $2.6B $1.9B $1.7B
Prepaid Expenses $333M $624M $746M $673M $702M
Other Current Assets $2B $2.5B $2B $2.4B $2.4B
Total Current Assets $9.3B $23.9B $20.9B $19.1B $19B
 
Property Plant And Equipment $35.6B $72.2B $70.1B $74.1B $70.8B
Long-Term Investments -- -- -- -- --
Goodwill $1.9B $11.1B $12.2B $12.2B $12.2B
Other Intangibles $36.6B $88.1B $97.3B $99.3B $99.3B
Other Long-Term Assets $1.9B $2.8B $3.2B $4.1B $4.2B
Total Assets $86.9B $200.2B $206.6B $211.3B $207.7B
 
Accounts Payable $4.3B $5.6B $6.5B $7.2B $5.6B
Accrued Expenses $1.6B $2.7B $2.6B $3.4B $3.1B
Current Portion Of Long-Term Debt $25M $4.6B $5.6B $5.2B $3.6B
Current Portion Of Capital Lease Obligations $3.2B $4.9B $4.5B $4.7B $4.8B
Other Current Liabilities $1.7B $810M $1.1B $1.9B $1.3B
Total Current Liabilities $12.5B $21.7B $23.5B $24.7B $20.9B
 
Long-Term Debt $24.9B $66.5B $68.6B $66.8B $71.4B
Capital Leases -- -- -- -- --
Total Liabilities $58.1B $134.8B $137.5B $141.7B $143B
 
Common Stock -- -- -- -- --
Other Common Equity Adj -$868M -$1.6B -$1.4B -$1B -$964M
Common Equity $28.8B $65.3B $69.1B $69.7B $64.7B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $28.8B $65.3B $69.1B $69.7B $64.7B
 
Total Liabilities and Equity $86.9B $200.2B $206.6B $211.3B $207.7B
Cash and Short Terms $1.5B $10.4B $6.6B $4.5B $5.1B
Total Debt $25B $71.1B $74.2B $72B $75B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $6.6B $4.1B $6.9B $5B $9.8B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $4.3B $4.1B $4.3B $4.5B $4.3B
Inventory $1.9B $1.8B $2.2B $1.7B $1.8B
Prepaid Expenses $659M $943M $711M $712M $953M
Other Current Assets $2.9B $1.6B $2.2B $2.2B $2.2B
Total Current Assets $19.5B $16.8B $21.4B $18.7B $22.5B
 
Property Plant And Equipment $69.6B $70.2B $73.9B $72B $66.8B
Long-Term Investments -- -- -- -- --
Goodwill $10.9B $12.2B $12.2B $12.2B $13B
Other Intangibles $88.6B $97.6B $99.5B $99.5B $101.5B
Other Long-Term Assets $2.5B $3.1B $3.9B $4.2B $5.2B
Total Assets $192.4B $202.1B $213.5B $208.6B $210.7B
 
Accounts Payable $3.9B $4.1B $6.8B $4.6B $3.1B
Accrued Expenses $2.5B $2.6B $3.4B $3.3B $2.8B
Current Portion Of Long-Term Debt $3.7B $4.3B $7.4B $3.4B $5.9B
Current Portion Of Capital Lease Obligations $4.7B $4.2B $4.6B $4.8B $4.6B
Other Current Liabilities $1.8B $939M $1.6B $2.9B $1.9B
Total Current Liabilities $19.8B $19.2B $26.4B $21.7B $21B
 
Long-Term Debt $63.1B $68.1B $66.3B $71.9B $74B
Capital Leases -- -- -- -- --
Total Liabilities $128B $133.7B $143.3B $143.9B $146.5B
 
Common Stock -- -- -- -- --
Other Common Equity Adj -$1.6B -$1.5B -$1.3B -$949M -$889M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $64.5B $68.4B $70.2B $64.7B $64.3B
 
Total Liabilities and Equity $192.4B $202.1B $213.5B $208.6B $210.7B
Cash and Short Terms $6.6B $4.1B $6.9B $5B $9.8B
Total Debt $66.8B $72.5B $73.7B $75.3B $79.9B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $3.5B $3.1B $3B $2.6B $8.3B
Depreciation & Amoritzation $6.6B $14.2B $16.4B $13.7B $12.8B
Stock-Based Compensation $495M $694M $540M $595M $667M
Change in Accounts Receivable -$4.7B -$4.7B -$6.4B -$6.3B -$4.9B
Change in Inventories -$617M -$2.2B $201M $744M $197M
Cash From Operations $6.8B $8.6B $13.9B $16.8B $18.6B
 
Capital Expenditures $7.4B $12.4B $21.7B $17.3B $10.8B
Cash Acquisitions -$31M -$3.8B -$1.9B -$52M --
Cash From Investing -$4.1B -$12.7B -$19.4B -$12.4B -$5.8B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- -$747M
Special Dividend Paid
Long-Term Debt Issued $2.3B $54.1B $14.7B $3.7B $8.4B
Long-Term Debt Repaid -$4.5B -$40.8B -$12.4B -$6.8B -$6.3B
Repurchase of Common Stock -- -$19.5B -- -$3B -$13.1B
Other Financing Activities -$201M -$527M -$623M -$370M -$444M
Cash From Financing -$2.4B $13B $1.7B -$6.5B -$12.1B
 
Beginning Cash (CF) $1.2B $1.5B $10.5B $6.7B $4.7B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $325M $8.9B -$3.8B -$2B $633M
Ending Cash (CF) $1.5B $10.5B $6.7B $4.7B $5.3B
 
Levered Free Cash Flow -$534M -$3.7B -$7.8B -$520M $7.7B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $1.3B $691M $508M $2.1B $3.1B
Depreciation & Amoritzation $4.2B $4.1B $3.3B $3.2B $3.2B
Stock-Based Compensation $161M $131M $150M $156M $170M
Change in Accounts Receivable -$1.8B -$984M -$1.3B -$881M -$806M
Change in Inventories -$549M $41M -$7M -$309M -$448M
Cash From Operations $2.8B $3.5B $4.4B $5.3B $6.1B
 
Capital Expenditures $3.2B $3.4B $4B $2.5B $4.4B
Cash Acquisitions $1.2B -$1.9B -- -- --
Cash From Investing -$1.1B -$4.2B -$2.6B -$1.4B -$3.3B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- -$758M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $2B $3B $2B $2.5B
Long-Term Debt Repaid -$6.2B -$4.9B -$443M -$4.8B -$570M
Repurchase of Common Stock -$2.5B -- -$557M -$2.7B -$560M
Other Financing Activities $7M -$107M -$45M -$34M -$85M
Cash From Financing -$6.1B -$3.1B $1.9B -$5.5B $507M
 
Beginning Cash (CF) $11.2B $7.9B $3.2B $6.8B $6.6B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$4.5B -$3.7B $3.8B -$1.6B $3.3B
Ending Cash (CF) $6.7B $4.1B $7B $5.2B $10B
 
Levered Free Cash Flow -$428M $126M $397M $2.8B $1.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $3.1B $3.4B $1.5B $7.8B $10.4B
Depreciation & Amoritzation $11.7B $16.7B $14.3B $12.8B $13.1B
Stock-Based Compensation $687M $539M $582M $650M $641M
Change in Accounts Receivable -$4.4B -$5.9B -$6.9B -$5B -$3.7B
Change in Inventories -$2.1B $295M -$319M $542M -$42M
Cash From Operations $6.7B $14.4B $15.4B $18B $21.6B
 
Capital Expenditures $9.3B $23B $16.9B $11.8B $11.6B
Cash Acquisitions -$3.8B -$1.9B -$52M -- -$390M
Cash From Investing -$10B -$21.1B -$12.1B -$6.8B -$8B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- -$3B
Special Dividend Paid
Long-Term Debt Issued $45.4B $20.4B $5.9B $9.2B $8.1B
Long-Term Debt Repaid -$37B -$15.5B -$5.5B -$8.5B -$4.7B
Repurchase of Common Stock -- -- -$557M -$13.3B -$8.7B
Other Financing Activities -$455M -$687M -$382M -$428M -$425M
Cash From Financing $8.3B $4.2B -$481M -$13.1B -$8.8B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $5B -$2.5B $2.8B -$1.8B $4.8B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$2.6B -$8.7B -$1.4B $6.2B $10B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $2.3B $2.6B $1.1B $6.3B $8.4B
Depreciation & Amoritzation $9.9B $12.5B $10.4B $9.5B $9.8B
Stock-Based Compensation $558M $403M $445M $500M $474M
Change in Accounts Receivable -$2.9B -$4B -$4.6B -$3.3B -$2.1B
Change in Inventories -$1.6B $904M $384M $182M -$57M
Cash From Operations $5.2B $10.9B $12.4B $13.7B $16.7B
 
Capital Expenditures $8.1B $18.7B $13.9B $8.4B $9.3B
Cash Acquisitions -$3.8B -$1.9B -$52M -- -$390M
Cash From Investing -$9.1B -$17.5B -$10.2B -$4.6B -$6.8B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- -$2.3B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $45.4B $11.8B $3B $8.4B $8.1B
Long-Term Debt Repaid -$36.3B -$11B -$4B -$5.7B -$4.2B
Repurchase of Common Stock -$19.5B -- -$557M -$10.9B -$6.5B
Other Financing Activities -$403M -$563M -$322M -$380M -$361M
Cash From Financing $9B $237M -$2B -$8.6B -$5.3B
 
Beginning Cash (CF) $13.8B $25.1B $13.2B $16.2B $18.9B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $5.1B -$6.3B $286M $525M $4.7B
Ending Cash (CF) $18.9B $18.8B $13.5B $16.7B $23.6B
 
Levered Free Cash Flow -$2.9B -$7.8B -$1.5B $5.3B $7.5B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock